
Welcome to the Royal College of Pharmacy
We’ve changed. You may know us as the Royal Pharmaceutical Society — on 15 April 2026, we became the Royal College of Pharmacy.


We are the Royal College of Pharmacy, the professional leadership body for pharmacists and pharmaceutical scientists. We exist to advance the safe and effective use of medicines, drive excellence in patient care and support pharmacists to deliver the highest standards of practice.
As the third largest workforce in healthcare, pharmacy plays a vital role in the health system, and as experts in medicines, pharmacists and their teams are central to patient care and public health. Our mission is to put pharmacy at the forefront of patient care, advancing the safe and effective use of medicines to the benefit of patients and the public.





Have any questions or comments on the new Royal College website?
Please visit our support page or email [email protected]
News
The latest news and updates from Royal College of Pharmacy
-
Foysol Choudhury MSP visits Barnton Pharmacy, Edinburgh
This news story was published when the organisation was the Royal Pharmaceutical Society. On 17 February 2025, Foysol Choudhury MSP for Lothian, visited the pharmacy team at Barnton Pharmacy in Edinburgh to witness the fantastic work they are doing to provide care to their local community. The visit was organised by Royal Pharmaceutical Society (RPS) in Scotland. Foysol met pharmacy manager, Leanne Carey, who has owned and run Barnton Pharmacy for 15 years. Leanne spoke about the fantastic one-to-one care which she provides to her patients. As an independent prescriber, Leanne offers her patients direct access to medicines for common conditions as appropriate, saving them time whilst also reducing pressure on local GP practices. Foysol also met with Glenn Davie, who has led on Barnton’s implementation of the Daffodil Standards for Community Pharmacy. The standards were developed by RPS in conjunction with Marie Curie, to support community pharmacies to offer the very best palliative, end-of-life and bereavement care to patients, families and carers. Fiona McIntyre, policy and practice lead at RPS explained the role of RPS in providing professional support to pharmacists working in all sectors and outlined some of RPS’s policy priorities, including, enabling pharmacy access to patient records, environmental sustainability and ensuring funding and training routes are in place to secure a continual pipeline of pharmacists entering the profession in Scotland and ultimately sustaining pharmacy for the future. Speaking about the visit, Foysol Choudhury MSP said: “This was a fantastic opportunity to witness first-hand the great work which the Barnton Pharmacy team is engaged in daily. I was really impressed to hear about the range of high-quality services which the team offers patients on a walk-in basis, from independent prescribing to palliative and end-of-life specialist support. In order that the pharmacy team can continue to deliver these services on behalf of the community, it is vital that the right infrastructure and support is in place to enable the team to provide the very best care. This includes enabling community pharmacists to have access to patient records; and ensuring funding is in place for pharmacy team workforce development, from funding for teaching and training prescribers to ensuring a healthy pipeline of pharmacy graduates for the future. I look forward to campaigning on these issues with my colleagues in the Scottish Parliament, to enable pharmacy to continue to provide a fantastic service for patients across Barnton, Lothians and across the whole of Scotland.” Read more RCPharm news stories.
-
Reclassification will help unlock access to medicines says RPS
This news story was published when the organisation was the Royal Pharmaceutical Society. The Royal Pharmaceutical Society welcomes the news from the Department of Health and Social Care encouraging more reclassification applications to the Medicines and Healthcare Products Regulatory Agency. RPS is a member of the Conditions & Category Working Group, which has worked with the MHRA to identify medicines which could be reclassified from ‘available only on prescription’ (POM) to ‘available in pharmacy’ (P) to improve opportunities for self care and to enable timely and more convenient access to medicines. Six broad health conditions have been identified where medicines could be reclassified to treat allergies, pain, skin problems, digestive disorders, women's health and oral health, based on international practice and real-world evidence. Reclassification of medicines enables people to be treated for specific conditions whilst receiving informed guidance, advice and support from their pharmacy team. President of the RPS Professor Claire Anderson said: "We welcome the news that applications for POM to P switches are being encouraged in six therapeutic areas. Reclassification can provide people with easier access to treatments for a range of symptoms and encourages self-care. “Diagnosing and discussing health problems with patients and advising on the benefits and risks of treatment options are integral to the role of the pharmacy team. “Enabling POM to P switches has a critical role to play in managing demand in primary care. It helps minimise unnecessary GP appointments and A&E attendances for minor conditions and ensures the public get the treatment they need from community pharmacies. “As the professional leadership body for pharmacists, RPS will work closely with the MHRA and manufacturers to provide guidance ensuring what is provided to the public continues to be safe and appropriate for their condition.” Read more RCPharm news stories.
-
RPS response to GPhC’s updated guidance on online pharmacy services
Following new GPhC guidance, RPS President Professor Claire Anderson emphasises the importance of patient–prescriber interactions.